bioAffinity Technologies, Inc. 8-K Report: Key Financial Insights as of January 2025

The provided XML section of the financial report contains key information about bioAffinity Technologies, Inc. as of January 10, 2025. Here are the most important extracted details:

1. Entity Information:

• Company Name: bioAffinity Technologies, Inc.
• CIK (Central Index Key): 0001712762
• Address: 3300 Nacogdoches Road, Suite 216, San Antonio, TX 78217
• Phone Number: (210) 698-5334

2. Filing Details:

• Form Type: 8-K (Current Report)
• Filing Date: January 10, 2025
• SEC File Number: 001-41463
• EIN (Employer Identification Number): 46-5211056

3. Stock Information:

• Common Stock Par Value: $0.007 per share
• Stock Class: Common Stock (identified as BIAF Common Stock Par Value $0.007 per Share)
• Tradeable Warrants: The company also has tradeable warrants for purchase of common stock (identified as BIAF Tradeable Warrants to Purchase Common Stock).

4. Context and Period:

• Reporting Date: The report is for the date January 10, 2025.
• Context IDs: Multiple context IDs are used, reflecting different segments and classes of stock.

5. Units of Measurement:

• The financial data is reported in USD (United States Dollar) and shares.

Insights:

• The company is actively reporting on its stock and warrants, indicating it may be engaged in financing activities or capital raising through these instruments.
• The low par value of the common stock suggests a strategy that allows for a greater number of shares to be issued, potentially to attract investment or facilitate transactions.
• Filing an 8-K indicates that the company is disclosing material events or corporate changes that may be important for investors and stakeholders.

This information provides a snapshot of bioAffinity Technologies, Inc.'s current financial position and activities as of the specified date.